| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $30.9B | $27.9B | $33.1B | $37.1B | $34.5B | $8.5B | $7.3B | $7.9B |
| Cost of Revenue | $27.4B | $24.6B | $29.0B | $32.3B | $30.3B | $25.5B | $25.6B | $26.0B |
| Gross Profit | $3.5B | $3.3B | $4.1B | $4.8B | $4.2B | $0.9B | $0.8B | $1.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.4B | $2.2B | $2.4B | $2.6B | $2.4B | $2.1B | $2.2B | $2.3B |
| Operating Income | $0.8B | $0.8B | $1.5B | $2.1B | $1.6B | $0.3B | $0.2B | $0.3B |
| Net Income | $0.6B | $0.4B | $0.9B | $1.4B | $1.1B | $0.2B | $0.1B | $0.2B |
| EPS (Basic) | $11.03 | $7.36 | $16.03 | $22.01 | $15.29 | $3.12 | $1.37 | $2.66 |
| EPS (Diluted) | $10.93 | $7.29 | $15.84 | $21.80 | $15.10 | $3.08 | $1.36 | $2.63 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.1B | $21.8B | $21.7B | $21.8B | $19.5B | $17.1B | $16.4B | $17.8B |
| Current Assets | $25.7B | $18.4B | $18.3B | $18.3B | $15.9B | $13.2B | $12.5B | $13.6B |
| Cash & Equivalents | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.4B | $0.3B | $0.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $18.8B | $12.6B | $13.2B | $12.4B | $11.3B | $9.1B | $8.3B | $8.8B |
| Stockholders' Equity | $6.6B | $5.8B | $5.8B | $5.5B | $5.3B | $5.1B | $4.8B | $5.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $1.1B | $0.7B | $-0.0B | $0.4B | $1.4B | $0.9B | $0.3B |
| Investing Cash Flow | $0.0B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.2B | $-0.5B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.2B | $-1.0B | $-0.7B | $0.1B | $-0.5B | $-1.2B | $-0.9B | $-0.0B |